tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:4AB Stock Latest News

AbbVie Stock Slides as Insider Selling Spooks Investors
Weekend UpdatesAbbVie Stock Slides as Insider Selling Spooks Investors
1d ago
ABBV
AbbVie, Alloy Therapeutics enter agreement to develop antibody platform
PremiumThe Fly
AbbVie, Alloy Therapeutics enter agreement to develop antibody platform
6d ago
ABBV
AbbVie’s Allergan Aesthetics launches Skin Quality Index
PremiumThe Fly
AbbVie’s Allergan Aesthetics launches Skin Quality Index
7d ago
ABBV
Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
PremiumRatings
Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
13d ago
ABBV
AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295
PremiumThe Fly
AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295
14d ago
ABBV
AbbVie Completes $8 Billion Senior Notes Financing Offering
PremiumCompany AnnouncementsAbbVie Completes $8 Billion Senior Notes Financing Offering
18d ago
8K
ABBV
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
Premium
The Fly
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
20d ago
ABBV
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
20d ago
ABBV
AbbVie Announces $7.5 Billion Senior Notes Offering
PremiumCompany Announcements
AbbVie Announces $7.5 Billion Senior Notes Offering
24d ago
8K
ABBV
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
PremiumThe Fly
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
24d ago
PFE
ABBV
AbbVie initiated with an Outperform at RBC Capital
PremiumThe Fly
AbbVie initiated with an Outperform at RBC Capital
26d ago
ABBV
AbbVie to invest $380M in two API manufacturing facilities at Illinois campus
PremiumThe Fly
AbbVie to invest $380M in two API manufacturing facilities at Illinois campus
27d ago
ABBV
Ideaya Biosciences appoints Theodora Ross as chief development officer
PremiumThe FlyIdeaya Biosciences appoints Theodora Ross as chief development officer
28d ago
ABBV
IDYA
FDA approves AbbVie venclexta, acalabrutinib supplemental new drug application
Premium
The Fly
FDA approves AbbVie venclexta, acalabrutinib supplemental new drug application
1M ago
ABBV
AbbVie initiated with an Overweight at Barclays
Premium
The Fly
AbbVie initiated with an Overweight at Barclays
1M ago
ABBV
AbbVie price target raised to $299 from $289 at Piper Sandler
PremiumThe Fly
AbbVie price target raised to $299 from $289 at Piper Sandler
1M ago
ABBV
Balanced Risk-Reward and Fading Upside Visibility Keep AbbVie at Market-Perform (Hold) with $225 Target
PremiumRatings
Balanced Risk-Reward and Fading Upside Visibility Keep AbbVie at Market-Perform (Hold) with $225 Target
1M ago
ABBV
AbbVie price target lowered to $230 from $240 at UBS
PremiumThe Fly
AbbVie price target lowered to $230 from $240 at UBS
2M ago
ABBV
AbbVie Earnings Call: New Growth Engines Take Lead
PremiumCompany Announcements
AbbVie Earnings Call: New Growth Engines Take Lead
2M ago
ABBV
AbbVie Buy Thesis Anchored by Robust Immunology Momentum, Neurology Upside, and Long-Term IBD Defense
PremiumRatingsAbbVie Buy Thesis Anchored by Robust Immunology Momentum, Neurology Upside, and Long-Term IBD Defense
2M ago
ABBV
AbbVie price target lowered to $228 from $232 at Evercore ISI
Premium
The Fly
AbbVie price target lowered to $228 from $232 at Evercore ISI
2M ago
ABBV
Clear Street says AbbVie move further validates Oruka Therapeutics’ strategy
Premium
The Fly
Clear Street says AbbVie move further validates Oruka Therapeutics’ strategy
2M ago
GSK
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >